Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

NCT00172003

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Novartis investigative Site Offenbach, Germany

View Trial Details

Completed

Sunitinib Malate in Treating Patients With Kidney Cancer

NCT00943839

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Centre Antoine Lacassagne Nice, France

View Trial Details

Completed

Bladder Cancer Patient-Reported Outcomes

NCT01090388

Conditions: Bladder Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

NCT00903175

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Alabama at Birmingham/ Kirklin Clinic Comprehensive CancerCenter (1) Birmingham, Alabama, United States

University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst. Mobile, Alabama, United States

Highlands Oncology Group HighlandsOncGrp-Bentonville(2) Fayetteville, Arkansas, United States

University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) La Jolla, California, United States

View all 84 locations

View Trial Details

Completed

An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)

NCT01392729

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cluj-Napoca, Romania

View Trial Details

Completed

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

NCT01170299

Conditions: Adnexal Diseases, Anal Cancer, Anus Diseases, +52 more
Locations: Royal Marsden - London London, England, United Kingdom

View Trial Details

Completed

Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma

NCT00808639

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Lahey Clinic Burlington, Massachusetts, United States

University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma

NCT01585974

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Many Locations, Turkey (Türkiye)

View Trial Details

Completed

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

NCT01522820

Conditions: Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details